Erlotinib Alpha-Medical 150 mg filmom obložene tablete
| Name | Erlotinib Alpha-Medical 150 mg filmom obložene tablete |
|---|---|
| Former Name | Erlotinib Alpha-Medical 150 mg filmom obložene tablete |
| Marketing Authorisation Number | HR-H-272495134 |
| Active Substance | erlotinibklorid |
| Composition | jedna filmom obložena tableta sadrži 150 mg erlotiniba (u obliku erlotinibklorida) |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Remedica Ltd., Limassol, Cipar |
| Marketing Authorisation Holder | Alpha-Medical d.o.o., Dragutina Golika 36, Zagreb, Hrvatska |
| Marketing Authorisation Date | 29.05.2024 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/21-02/61 |
| Registration Number | 381-12-01/171-24-24 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L01EB02 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Educational materials for healthcare professionals |
Brošura za zdravstvene radnike, verzija 2 |
